Skip to main navigation Skip to search Skip to main content

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials

  • University of Aberdeen
  • Health Service Research Unit

Research output: Contribution to journalLetterpeer-review

Abstract

We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.

Original languageEnglish
Article number93
JournalTrials
Volume24
Issue number1
DOIs
Publication statusPublished - Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions

Keywords

  • Clinical trials
  • Outcomes
  • Patient and public involvement/PPI
  • Trial methodology

Fingerprint

Dive into the research topics of 'Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials'. Together they form a unique fingerprint.

Cite this